home / stock / vect / vect news


VECT News and Press, VectivBio Holding AG From 06/15/21

Stock Information

Company Name: VectivBio Holding AG
Stock Symbol: VECT
Market: NASDAQ
Website: vectivbio.com

Menu

VECT VECT Quote VECT Short VECT News VECT Articles VECT Message Board
Get VECT Alerts

News, Short Squeeze, Breakout and More Instantly...

VECT - Dosing underway in VectivBio's mid-stage apraglutide study in short bowel syndrome

VectivBio Holding ([[VECT]] +1.9%) has dosed the first patient in its Phase 2 STARS Nutrition metabolic balance study evaluating apraglutide in colon-in-continuity ((CIC)) patients with short bowel syndrome with intestinal failure (SBS-IF). This Phase 2 trial is designed to evaluate the effic...

VECT - VectivBio Announces First Patient Dosed in Metabolic Balance Study of Apraglutide in Colon-in-Continuity Patients with Short Bowel Syndrome with Intestinal Failure

Phase 2 trial will evaluate the efficacy of once-weekly apraglutide in increasing intestinal energy absorption in CIC patients with SBS-IF CIC patients represent over half of the total SBS-IF population Initial readout of 4-week intestinal energy absorption data expected in 1H...

VECT - VectivBio names new chief medical officer, chief operating officer

VectivBio (VECT) has named Omar Khwaja as its new chief medical officer.In addition, Christian Meyer was appointed to the new position of chief operating officer.Khwaja was previously CMO at Voyager Therapeutics, while Meyer, a founding member of the company, was previously CMO at Therachon A...

VECT - VectivBio names Omar Khwaja as chief medical officer

VectivBio Holding (VECT) announces the appointment of Omar Khwaja as the company's chief medical officer.The move means that Christian Meyer will move to the newly created position of chief operating officer, the company said.Khwaja has over two decades of experience, and ...

VECT - VectivBio Appoints Omar Khwaja, M.D., Ph.D., as Chief Medical Officer

Christian Meyer, currently Chief Development Officer, to assume the newly created position of Chief Operating Officer Senior leadership appointments strengthen VectivBio as it continues development of apraglutide in short bowel syndrome and graft versus host disease, and expansion...

VECT - Quest upgraded while Teva downgraded at UBS, and VectiveBio scores two new buy initiations in today's analyst action

Growth beyond COVID for Quest DiagnosticsQuest Diagnostics (DGX) is poised for top-line growth even as COVID-19 testing wanes, according to UBS, which has upgraded shares from neutral to buy.Analyst Kevin Caliendo has also upped his price target to $158 from $135, implying upside of 19% from ...

VECT - Wall Street Breakfast: The Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead A barrage of earnings reports will arrive next week. The Q1 earnings season so far has seen a record 87% of S&P 500 ...

Previous 10 Next 10